Stability and Characterization of Protein and Peptide Drugs: Case Histories: 5 (Pharmaceutical Biotechnology, 5) - Image 1

£149.86

Springer Stability and Characterization of Protein and Peptide Drugs: Case Histories: 5 (Pharmaceutical Biotechnology, 5)

Name: Stability and Characterization of Protein and Peptide Drugs: Case Histories: 5 (Pharmaceutical Biotechnology, 5)
Brand: Springer
Price: 149.86 GBP
Availability: InStock

Pharmacy - Dispensing

This is the most expensive it has ever been. Walk away.

£150 today · previous high £150 · all-time low £149

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey

↓ Forecast
where the price is heading next

↓ Statistics
all-time high & low, recent range

↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 42 days • 42 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 42 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £150 (34 days, 81.0%)

Price range: £149 - £150

Price levels: 2 different prices over 42 days

Description

This volume attemptsto provide the formulation scientist with casehistories involving the use of therapeutic proteins and peptides that have been mar- keted or are under clinical testing. In previous volumes of this series,funda- mental theories and principles ofprotein characterization and stability were presented in depth by researchers in their fieldsofexpertise. The way from theory to practice isnot alwaysobvious and straightforward. There isa need for practical examples of how the principles and theories are put into use, specificallyin the development of a pharmaceutical product. It is our hope that this volume will fulfillsuch a need. Itisnot asimple task to choose a panel ofproteinsand peptides from the over 200 agents in human clinical trials. We have tried to collect a wide representation of molecules of different sizes-from 10 amino acids (Leu- prolide) to 1020 amino acids (Muromonab CD3). The examples include agents derived from various sources including monoclonal antibodies (Mur- omonab CD3), recombinant DNA (human and bovine growth hormones), natural source (fibrolase), and chemical synthesis (Leuprolide). Clearly this list is not intended to be encyclopedic. It isthe first time a collection of this sort has been made accessibleto the formulation scientists involved in devel- oping protein and peptide products. Although each chapter in this volume focuses primarily on the charac- terization and stability of a specific molecule, each has unique aspects.

Product Specifications

Brand: Springer
Format: paperback
ASIN: 148991238X
Category: Books > Subjects > Health, Family & Lifestyle > Medical & Healthcare Practitioners > Allied Health Professions > Pharmacy - Dispensing
Domain: Amazon UK
Release Date: 31 May 2013
Listed Since: 18 April 2014

Barcode

No barcode data available

Springer Stability and Characterization of Protein and Peptide Drugs: Case Histories: 5 (Pharmaceutical Biotechnology, 5)

This is the most expensive it has ever been. Walk away.

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Springer - Stability and Characterization of Protein Drugs Vol 5

Co- and Post-Translational Modifications of Therapeutic Antibodies and Proteins

CRC Press Therapeutic Peptides and Proteins, 3rd Edition

Challenges in Protein Product Development: 38 (AAPS Advances in the Pharmaceutical Sciences Series, 38)

Therapeutic Protein Drug Products: Practical Approaches to formulation in the Laboratory, Manufacturing, and the Clinic (Woodhead Publishing Series in Biomedicine)

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Humana Peptide-Based Drug Design: 494 Methods in Molecular Biology

CRC Press - Pharmaceutical Formulation of Peptides and Proteins

Development of Biopharmaceutical Drug-Device Products: 35 (AAPS Advances in the Pharmaceutical Sciences Series, 35)

Drug Discovery and Development: Technology in Transition

Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals

Approaches to the Conformational Analysis of Biopharmaceuticals (Protein Science)

Approaches to the Conformational Analysis of Biopharmaceuticals (Protein Science)

Development and Manufacture of Protein Pharmaceuticals: 14 (Pharmaceutical Biotechnology, 14)

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

The Challenge of CMC Regulatory Compliance for Biopharmaceuticals

Wiley - Biological Drug Products: Development and Strategies

Development of In-Tether Carbon Chiral Center-Induced Helical Peptide: Methodology and Applications (Springer Theses)

Development of In-Tether Carbon Chiral Center-Induced Helical Peptide: Methodology and Applications (Springer Theses)

Peptide Modifications to Increase Metabolic Stability and Activity: 1081 (Methods in Molecular Biology, 1081)

Pharmaceutical Dosage Forms - Parenteral Medications: Volume 3: Regulations, Validation and the Future

CPP, Cell-Penetrating Peptides

Pharmaceutical Dosage Forms - Parenteral Medications: Volume 1: Formulation and Packaging

Springer Handbook of Stability Testing in Pharmaceutical Development